Founded in April 2006, Concert Pharmaceuticals is a clinical stage biotechnology company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium.
Concert applies its innovative precision deuterium chemistry platform to modify specific properties of validated drug molecules, yielding a rich pipeline of new chemical entities (NCEs). Concert leverages decades of pharmaceutical experience to create novel drug candidates with potential for best-in-class efficacy and safety, while greatly reducing R&D risk, time and expense.
Current Team (6)Update
Past Team (4)Update
Funding Rounds (4) - $99.5MUpdate
HIV, TB pharmaceuticals
QVT Financial LP is a privately owned hedge fund sponsor. The firm provides its services to...
Venture capital Firm
Westfield Capital Management is an SEC-registered investment advisor dedicated to providing...
Three Arch Partners was formed in 1993 to provide young companies with access to relevant...
Skyline Ventures, formed in 1997, is a nationally-known venture capital firm that specializes in...
99 Hayden Avenue
Lexington, MA 02421
- 02/13/14 -nasdaq.com